Genetic Engineering News and Research

RSS

Astrazeneca To Use Wyss Institute’s Organs-On-Chips

AstraZeneca has taken a small step in reducing the need for traditional animal testing by signing on to evaluate Organs-on-Chips from the Wyss Institute for Biologically Inspired Engineering at Harvard.

16 Oct 2013

CEO Faces Felony Charge Of Computer Trespass

...

16 Oct 2013

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

...

16 Oct 2013

UC researchers receive $2.1M grant from NIH to study molecular mechanisms of muscle fatigue

University of Cincinnati (UC) researchers have been awarded a five-year, $2.1 million grant from the National Institutes of Health (NIH) to study an isoform that plays a critical role in human resistance to fatigue.

16 Oct 2013

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

...

15 Oct 2013

New injection device to reduce fear and pain of injecting modern medicines

...

15 Oct 2013

Astrazeneca Acquires Spirogen For Up To $440M

...

15 Oct 2013

Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

...

11 Oct 2013

Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

...

11 Oct 2013

Yale Launches Collaboration With ARO, CRO Partners

...

11 Oct 2013

Auxilium Licenses Stendra From Vivus For Up To $300M

...

11 Oct 2013

New gene transfer strategy effective for achieving persistent immunotherapy to treat tumors

Cancer immunotherapy can successfully use the body's own immune system to kill tumor cells. But some current approaches to stimulate an antitumor immune response are short-lived, with limited clinical effectiveness. A new gene transfer strategy that introduces modified, immune-stimulating human stem cells is both feasible and effective for achieving persistent immunotherapy to treat leukemias and lymophomas, according to a study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

11 Oct 2013

People who live in coal mining regions face increased risk depression

People who live among the destructive environmental effects of mountaintop coal mining face an increased risk of major depression. The results of a study conducted in the coal mining regions of Central Appalachia that explored the relationship between psychological health and environmental degradation are published in Ecopsychology, a peer-reviewed, online journal from Mary Ann Liebert, Inc., publishers.

11 Oct 2013

Diverse Neurological Disorders Appear To Share Tangled Metabolic Roots

...

10 Oct 2013

Teva Cutting 5,000 Jobs In Global Restructuring

...

10 Oct 2013

Nuvo Scores $2M Payment From Galderma For Launch Of Topical Anesthetic In Brazil

...

10 Oct 2013

J&J Innovation, Janssen, And Joslin Diabetes To Pump Up Exercise-Related Targets

...

10 Oct 2013

Vivaldi Buys Flu Vaccine R&D Assets From Baxter

...

10 Oct 2013

Uterine fibroids disproportionately impact African American women

A national survey has found that uterine fibroids have a disproportionate impact on African American women, causing more severe symptoms, interfering with their daily life, and causing them to miss work. These new findings are reported in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

10 Oct 2013